Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates

Eton Pharmaceuticals, Inc. (ETON) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of $0.13. This compares to earnings of $0.02 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -153.85%. A quarter ago, it was expected that this company would post a loss of $0.01 per share when it actually produced a loss of $0.1, delivering a surprise of -900%.Over the last four quarters, the company has not ...